| Inhibition of p38 activity
prevents formation of nascent keratin
granules. Time-lapse recording of HK13-EGFP fluorescence (left, inverse
presentation) and corresponding phase contrasts with overlaid HK13-EGFP
fluorescence (right) in AK13-1 cells prior to and during treatment with
the p38 inhibitor SB202190 (100 μM; corresponding Fig. 10 A, A').
../../images were recorded every 20 s (display rate: 29 frames/s). Note the
retraction of the KF network except for desmosome-anchored filaments in
response to the drug while dynamic filopodia are still abundant and
ruffling continues | Inhibition
of p38 activity prevents formation of nascent keratin
granules and disassembly of keratin granules in cells producing mutant
keratins. Time-lapse recording of HK14R125C-EYFP fluorescence at left
(inverse presentation) and corresponding phase contrast ../../images together
with overlaid EYFP-K14R125C- fluorescence micrographs at right of
MT5K14-26 cells before, during and after a short treatment with the p38
inhibitor SB202190 (100 μM; corresponding Fig. 10 B - B''). ../../images were
recorded every 20 s and are displayed at 30 frames/s. Note the
transient cessation of keratin granule formation and stabilization of
pre-existing keratin granules upon drug administration.
| Inhibition of p38 activity
stabilizes mutant keratin granules.
Time-lapse recording (3 ../../images/ min; display rate 25 frames/s) of
HK14R125C-EYFP fluorescence at left (inverse presentation) and
corresponding phase contrast ../../images at right before and after addition
of the p38 inhibitor SB202190 (50 μM). The upper right corners extend
beyond the image fields. Note the immediate cessation of granule
disassembly upon drug addition of the drug. |